Updated on 11 September 2026
Expertise for HORIZON-HLTH-2027-02-DISEASE-01 (two-stage)
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania
About
LSMU offers broad expertise in clinical research, public health, prevention, and management of non-communicable diseases across multiple medical disciplines. The institution has extensive experience in designing and implementing clinical studies evaluating innovative healthcare interventions and treatment strategies. Through its university hospital infrastructure, LSMU can support patient recruitment, clinical validation, outcome assessment, and implementation research. The institution is particularly interested in approaches that integrate personalized medicine, digital health technologies, and evidence-based care pathways to improve patient outcomes. Participation in international research consortia would contribute to the development and evaluation of innovative solutions addressing the growing burden of non-communicable diseases in Europe.
Topic
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
Similar opportunities
Project cooperation
VUMF expertise for HORIZON-HLTH-2027-01-DISEASE-10
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Giedre Kvedaraviciene
Director, Lithuanian population & rare disorders biobank, Vilnius University Faculty of Medicine at Vilnius University
Vilnius, Lithuania
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-04
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Erika Korobeinikova
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-03
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Erika Korobeinikova
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania